IMPCL registers impressive threefold increase in profit for FY21-22
News

IMPCL registers impressive threefold increase in profit for FY21-22

The dividend cheque of Rs. 9.93 crore for the Ministry of Ayush was handed over to Sonowal

  • By IPP Bureau | November 11, 2022

Indian Medicines Pharmaceutical Corporation (IMPCL), a central public sector enterprise (CPSE), under the Ministry of Ayush, Government of India, has announced to pay a dividend of Rs. 10.13 crore to its stakeholders - Ministry of Ayush and Government of Uttarakhand.

The dividend cheque of Rs. 9.93 crore for the Ministry of Ayush was handed over to Union Minister of Ayush Sarbananda Sonowal in a ceremony held at Transport Bhawan.

On this occasion, Sarbananda Sonowal said, “IMPCL Ltd. has registered an impressive increase in its profits in comparison to the last FY 2020-21, which is commendable achievement. Under the visionary leadership of Prime Minister Narendra Modi, the Ayush sector is witnessing all round growth not only in India but globally.”

The dividend cheque handover ceremony was attended by MoS for Ayush Majapara Mahendrabhai; Special Secretary, Ministry of Ayush Pramod Kumar Pathak; Director Yoga and Naturopathy cell, Ministry of Ayush Vikram Singh; Advisor Ayurveda, Dr. Mukesh Kumar, MD, IMPCL Ltd.; and Arvind Kumar Aggarwal, AGM (F&A), IMPCL Ltd.

Dr. Mukesh Kumar, MD, IMPCL Ltd. said, “In the operational front, the company has achieved an enhancement of 47% in capacity utilization over its previous year. An all-around enhancement in performance in terms of turnover, profit, and capacity utilization over previous years has brought focus on the future prospects of the company.” 

The company is presently manufacturing 656 Classical Ayurvedic, 332 Unani, and 71 Proprietary Ayurvedic Medicines for the various diseases spectrum. It supplies Ayurveda and Unani medicines to all the states under National Ayush Mission (NAM) and 6,000 centres of Jan Aushadhi Kendras.

Upcoming E-conference

Other Related stories

Startup

Digitization